Peter Leigh

986 total citations
17 papers, 625 citations indexed

About

Peter Leigh is a scholar working on Neurology, Genetics and Molecular Biology. According to data from OpenAlex, Peter Leigh has authored 17 papers receiving a total of 625 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Neurology, 8 papers in Genetics and 3 papers in Molecular Biology. Recurrent topics in Peter Leigh's work include Amyotrophic Lateral Sclerosis Research (10 papers), Neurogenetic and Muscular Disorders Research (8 papers) and Parkinson's Disease Mechanisms and Treatments (7 papers). Peter Leigh is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (10 papers), Neurogenetic and Muscular Disorders Research (8 papers) and Parkinson's Disease Mechanisms and Treatments (7 papers). Peter Leigh collaborates with scholars based in United Kingdom, France and United States. Peter Leigh's co-authors include Stella A. Glasmacher, Ammar Al‐Chalabi, M. T. Jackson, Karen Morrison, Barry A. Chioza, Zinat E. Enayat, Barbara Tomik, Pierre‐François Pradat, Katja Kollewe and Peter M. Andersen and has published in prestigious journals such as PLoS ONE, Neurology and Annals of Neurology.

In The Last Decade

Peter Leigh

16 papers receiving 606 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Leigh United Kingdom 11 535 240 99 98 84 17 625
Bryan Traynor United States 2 691 1.3× 430 1.8× 96 1.0× 152 1.6× 58 0.7× 2 767
Bernie Corr Ireland 11 734 1.4× 429 1.8× 124 1.3× 136 1.4× 58 0.7× 11 855
Helen Stephens United States 15 517 1.0× 252 1.1× 108 1.1× 81 0.8× 41 0.5× 25 640
Peter Kühnlein Germany 10 337 0.6× 200 0.8× 50 0.5× 65 0.7× 48 0.6× 13 536
Marie Nicol France 11 584 1.1× 371 1.5× 83 0.8× 109 1.1× 30 0.4× 18 658
Stefania Cammarosano Italy 14 810 1.5× 359 1.5× 112 1.1× 114 1.2× 66 0.8× 24 920
Antonio Ilardi Italy 11 550 1.0× 275 1.1× 93 0.9× 94 1.0× 47 0.6× 20 634
Bryan Traynor United States 11 950 1.8× 575 2.4× 177 1.8× 249 2.5× 91 1.1× 20 1.1k
Anna Montuschi Italy 13 893 1.7× 358 1.5× 112 1.1× 118 1.2× 105 1.3× 16 1.0k
Christian Burkhardt Switzerland 9 432 0.8× 267 1.1× 33 0.3× 50 0.5× 35 0.4× 9 523

Countries citing papers authored by Peter Leigh

Since Specialization
Citations

This map shows the geographic impact of Peter Leigh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Leigh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Leigh more than expected).

Fields of papers citing papers by Peter Leigh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Leigh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Leigh. The network helps show where Peter Leigh may publish in the future.

Co-authorship network of co-authors of Peter Leigh

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Leigh. A scholar is included among the top collaborators of Peter Leigh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Leigh. Peter Leigh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Bensimon, Gilbert, William Camu, Christine Payan, et al.. (2017). IMMUNO-MODULATION IN AMYOTROPHIC LATERAL SCLEROSIS - A PHASE II STUDY OF SAFETY AND ACTIVITY OF LOW DOSE INTERLEUKIN-2 (IMODALS study) (S3.006). Neurology. 88(16_supplement). 1 indexed citations
2.
Glasmacher, Stella A., et al.. (2017). Predictors of survival in progressive supranuclear palsy and multiple system atrophy: a systematic review and meta-analysis. Journal of Neurology Neurosurgery & Psychiatry. 88(5). 402–411. 94 indexed citations
3.
Al‐Sarraj, Safa, Andrew King, Andrea M. Corse, et al.. (2014). Mitochondrial abnormalities and low grade inflammation are present in the skeletal muscle of a minority of patients with amyotrophic lateral sclerosis; an observational myopathology study. Acta Neuropathologica Communications. 2(1). 165–165. 42 indexed citations
4.
Al‐Chalabi, Ammar, Shin Kwak, Mark F. Mehler, et al.. (2013). Genetic and epigenetic studies of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 14(sup1). 44–52. 25 indexed citations
5.
Scotton, William J., Kirsten M. Scott, Dan H. Moore, et al.. (2012). Prognostic categories for amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis. 13(6). 502–508. 22 indexed citations
6.
Higginson, Irene J, Wei Gao, Tariq Saleem, et al.. (2012). Symptoms and Quality of Life in Late Stage Parkinson Syndromes: A Longitudinal Community Study of Predictive Factors. PLoS ONE. 7(11). e46327–e46327. 76 indexed citations
7.
Payán, C., François Viallet, G. Bernhard Landwehrmeyer, et al.. (2011). Disease Severity and Progression in Progressive Supranuclear Palsy and Multiple System Atrophy: Validation of the NNIPPS – PARKINSON PLUS SCALE. PLoS ONE. 6(8). e22293–e22293. 56 indexed citations
8.
Andersen, Peter M., Gian Domenico Borasio, Reinhard Dengler, et al.. (2007). Good practice in the management of amyotrophic lateral sclerosis: Clinical guidelines. An evidence‐based review with good practice points. EALSC Working Group. Amyotrophic Lateral Sclerosis. 8(4). 195–213. 136 indexed citations
9.
Hughes, Richard A., et al.. (2004). Building user involvement in motor neurone disease: key lessons.. PubMed. 18(1). 80–1. 1 indexed citations
10.
Fujita, Yukio, Masakuni Amari, Masamitsu Takatama, et al.. (2004). Morphological differences of intraneuronal ubiquitin‐positive inclusions in the dentate gyrus and parahippocampal gyrus of motor neuron disease with dementia. Neuropathology. 24(4). 296–301. 10 indexed citations
11.
Higginson, Irene J, et al.. (2002). The challenges for policies and practices relating to MND health and social care. 13th International Symposium on ALS/ MND, Melbourne. Research Portal (King's College London). 1 indexed citations
12.
Shaw, Christopher E., et al.. (2001). Society for Neuroscience Abstracts. 8 indexed citations
13.
Ellis, C. M., et al.. (1998). A proton magnetic resonance spectroscopic study in ALS. 51(4). 4 indexed citations
14.
Jackson, M. T., Ammar Al‐Chalabi, Zinat E. Enayat, et al.. (1997). Copper/zinc superoxide dismutase 1 and sporadic amyotrophic lateral sclerosis: Analysis of 155 cases and identification of novel insertion mutation. Annals of Neurology. 42(5). 803–807. 100 indexed citations
15.
Jackson, M. T., et al.. (1996). Analysis of chromosome 5q13 genes in amyotrophic lateral sclerosis: Homozygous naip deletion in a sporadic case. Annals of Neurology. 39(6). 796–800. 38 indexed citations
16.
Garofalo, O., Denise A. Figlewicz, S.M. Thomas, et al.. (1995). Superoxide dismutase activity in lymphoblastoid cells from motor neurone disease/amyotrophic lateral sclerosis (MND/ALS) patients. Journal of the Neurological Sciences. 129. 90–92. 10 indexed citations
17.
Leigh, Peter. (1989). Investors, taxation and the housing boom. Urban Policy and Research. 7(4). 181–183. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bryan Traynor Breakdown of academic impact, for papers by Bernie Corr Breakdown of academic impact, for papers by Helen Stephens Breakdown of academic impact, for papers by Peter Kühnlein Breakdown of academic impact, for papers by Marie Nicol Breakdown of academic impact, for papers by Stefania Cammarosano Breakdown of academic impact, for papers by Antonio Ilardi Breakdown of academic impact, for papers by Bryan Traynor Breakdown of academic impact, for papers by Anna Montuschi Breakdown of academic impact, for papers by Christian Burkhardt
Rankless by CCL
2026